StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Rajesh Palviya, Axis Securities

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))19 May 2026via CNBC Awaaz.

Entry₹1,860Stated
Target₹2,040
Total upside +9.68% (call closed)
Stop lossNot given
At expiry₹1,789.12 Jun 2026, 3:30 pm
Expired-3.81%
Follow Rajesh Palviya for new calls(27% target hit, 178 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:51 pm IST
3 supporting2 neutral0 opposing
Supports the BUY call (3)

Sun Pharma to present long-term follow-up data on UNLOXCYT (cosibelimab-ipdl) at ASCO 2026 Annual Meeting.

NSE · Press Release·26 May · 6d ago

(opens in new tab)

Sun Pharma to present pivotal long-term follow-up data on UNLOXCYTTM (cosibelimab-ipdl) at the ASCO 2026 Annual Meeting. Data shows 50% objective response rate, including 27% complete responses, with

BSE · Company Update·26 May · 6d ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·22 May · 1w ago

Neutral / worth noting (2)

Sun Pharmaceutical Industries Limited has submitted to the Exchange, the Audited Financial Results for the quarter and year ended 31 March 2026.

NSE · Outcome of Board Meeting·22 May · 2w ago

(opens in new tab)

CRISIL and ICRA have reaffirmed Sun Pharma's long-term bank facilities ratings at 'AAA' and short-term ratings at 'A1+'. CRISIL has placed the long-term rating on 'Rating Watch with Developing Implica

BSE · Company Update·7 May · 4w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Rajesh Palviya, Axis Securities

Every call and its outcome